B3GAT1 and COVID-19: Consistent with previous reports (27), we found that CD56dim NK cells from hospitalized COVID-19 patients, compared to controls, show a reduced percentage of cells expressing CD16 (Fig. S8A), an increased percentage of cells expressing CD57 (Fig. S8B), and a reduced percentage of cells expressing Siglec-7 (Fig. S8C).